Tauopathy Biochemistry

Tauopathies are neurodegenerative disorders that are caused due to the accumulation of abnormal tau proteins in neurons and/or the glia. Here is the latest research on tauopathy biochemistry.

December 6, 2021

With No Lysine Kinase 1 Promotes Metabolic Derangements and RV Dysfunction in Pulmonary Arterial Hypertension.

JACC. Basic to Translational Science
Sasha Z PriscoKurt W Prins
December 6, 2021
Review
Open Access

Recent High-Resolution Structures of Amyloids Involved in Neurodegenerative Diseases.

Frontiers in Aging Neuroscience
Rodrigo Diaz-Espinoza
December 6, 2021
Review
Open Access

Exploration of Aberrant E3 Ligases Implicated in Alzheimer's Disease and Development of Chemical Tools to Modulate Their Function.

Frontiers in Cellular Neuroscience
Frances M Potjewyd, Alison D Axtman
December 6, 2021

Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease.

Journal of Alzheimer's Disease : JAD
Alessio CrestiniVincenzo Mattei
December 5, 2021

β-arrestin1 promotes tauopathy by transducing GPCR signaling, disrupting microtubules and autophagy.

Life Science Alliance
Jung-Aa WooDavid E Kang
December 4, 2021
Review
Open Access

NMR Studies of Tau Protein in Tauopathies.

Frontiers in Molecular Biosciences
Kristine KitokaKristaps Jaudzems
December 4, 2021
Review
Open Access

Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology.

Frontiers in Cell and Developmental Biology
Rebekka KühnGunnar Hargus
December 3, 2021

Microtubule-modulating agents in the fight against neurodegeneration: Will it ever work?

Current Neuropharmacology
Ahmed SolimanRoland Brandt
December 3, 2021

Tau phosphorylation sites serine202 and serine396 are differently altered in chronic traumatic encephalopathy and Alzheimer's disease.

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
SpiroAnthony StathasThor D Stein
December 3, 2021

Hydromethylthionine enhancement of central cholinergic signalling is blocked by rivastigmine and memantine.

Journal of Neurochemistry
Constantin KondakJochen Klein
December 3, 2021

The metabolic signaling of the nucleoredoxin-like 2 gene supports brain function.

Redox Biology
Céline JaillardThierry Léveillard
November 29, 2021

Post-translational modifications within tau paired helical filament nucleating motifs perturb microtubule interactions and oligomer formation.

The Journal of Biological Chemistry
Diana M AcostaDavid Eliezer
November 28, 2021
Review

Examining the Toxicity of α-Synuclein in Neurodegenerative Disorders.

Life
Frank Y ShanJason H Huang

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/tauopathy-biochemistry/cf253c17-da4c-4ee5-912f-deed325b7c13